CONDENSED STATEMENTS OF REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS’ EQUITY (DEFICIT) (Unaudited) - USD ($) $ in Thousands	Total	Series A Redeemable Convertible Preferred Stock	Series B Redeemable Convertible Preferred Stock	Series C Redeemable Convertible Preferred Stock	Common Stock	Additional Paid-In Capital	Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2020		8,350,743	46,176,715	28,998,607
Beginning balance at Dec. 31, 2020		$ 7,519	$ 66,186	$ 102,618
Ending balance (in shares) at Jun. 30, 2021		8,350,743	46,176,715	28,998,607
Ending balance at Jun. 30, 2021		$ 7,519	$ 66,186	$ 102,618
Beginning balance (in shares) at Dec. 31, 2020					27,995,780
Beginning balance at Dec. 31, 2020	$ (101,400)				$ 0	$ 9,036	$ (110,436)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of common stock options (in shares)					1,048,706
Exercise of common stock options	258					258
Exercise of common stock warrant (in shares)					84,118
Exercise of common stock warrant	77					77
Stock-based compensation expense from issuance of a fully vested warrant to vendor	1,239					1,239
Vesting of early exercised stock options	63					63
Stock-based compensation	5,591					5,591
Net (loss) income	32,840						32,840
Ending balance (in shares) at Jun. 30, 2021					29,128,604
Ending balance at Jun. 30, 2021	(61,332)				$ 0	16,264	(77,596)
Beginning balance (in shares) at Mar. 31, 2021		8,350,743	46,176,715	28,998,607
Beginning balance at Mar. 31, 2021		$ 7,519	$ 66,186	$ 102,618
Ending balance (in shares) at Jun. 30, 2021		8,350,743	46,176,715	28,998,607
Ending balance at Jun. 30, 2021		$ 7,519	$ 66,186	$ 102,618
Beginning balance (in shares) at Mar. 31, 2021					28,618,529
Beginning balance at Mar. 31, 2021	(85,270)				$ 0	12,135	(97,405)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of common stock options (in shares)					425,957
Exercise of common stock options	227					227
Exercise of common stock warrant (in shares)					84,118
Exercise of common stock warrant	77					77
Stock-based compensation expense from issuance of a fully vested warrant to vendor	1,239					1,239
Vesting of early exercised stock options	17					17
Stock-based compensation	2,569					2,569
Net (loss) income	19,809						19,809
Ending balance (in shares) at Jun. 30, 2021					29,128,604
Ending balance at Jun. 30, 2021	(61,332)				$ 0	16,264	(77,596)
Beginning balance (in shares) at Dec. 31, 2021					146,402,991
Beginning balance at Dec. 31, 2021	$ 706,750				$ 1	730,767	(24,018)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of common stock options (in shares)	515,705				514,191
Exercise of common stock options	$ 512					512
Tax withholding on exercise of stock options and issuance of shares from restricted stock units	(3,468)					(3,468)
Shares issued from restricted stock units (in shares)					917,195
Stock-based compensation	32,826					32,826
Net (loss) income	(96,247)						(96,247)
Ending balance (in shares) at Jun. 30, 2022					147,834,377
Ending balance at Jun. 30, 2022	640,373				$ 1	760,637	(120,265)
Beginning balance (in shares) at Mar. 31, 2022					146,958,296
Beginning balance at Mar. 31, 2022	725,138				$ 1	746,352	(21,215)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of common stock options (in shares)					219,960
Exercise of common stock options	242					242
Tax withholding on exercise of stock options and issuance of shares from restricted stock units	(2,749)					(2,749)
Shares issued from restricted stock units (in shares)					656,121
Stock-based compensation	16,792					16,792
Net (loss) income	(99,050)						(99,050)
Ending balance (in shares) at Jun. 30, 2022					147,834,377
Ending balance at Jun. 30, 2022	$ 640,373				$ 1	$ 760,637	$ (120,265)